Minerals Technologies vs Valhi
MTX and VHI side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MTX and VHI compare
Minerals Technologies is the larger company, worth 4.1 times as much as Valhi ($1.9B against $467M).
Valhi grew revenue faster over the last twelve months (9.0% versus 4.8% for Minerals Technologies).
Valhi keeps more of each dollar of sales as profit, with a net margin of 0.06% compared with −3.1% at Minerals Technologies.
Both pay dividends: Minerals Technologies yields 0.58% and Valhi 1.9%.
Valhi scores higher on the StockData Score (12 against 7 for Minerals Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MTX | VHI |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $467M |
| Share price | $62.12 | $16.49 |
| Change, 1 year | 9.5% | 22.0% |
| Change, 5 years | −14.1% | −38.5% |
| Beta (5Y) | 0.95 | 0.96 |
| Employees | 216 | 549 |
| StockData Score | ||
| Total score | 7 | 12 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 3 | 3 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/S | 0.9× | 0.2× (better) |
| P/B | 1.2× | 0.4× (better) |
| EV/EBITDA | – | 5.6× |
| P/FCF | 15.0× | 3.9× (better) |
| FCF yield | 6.7% | 25.4% (better) |
| Fair value | $58.95 | $82.88 |
| Margin of safety | −5.4% | 80.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.8% | 9.0% (better) |
| Revenue growth, 5Y average | 5.4% (better) | 2.3% |
| Net income growth (TTM) | – | −92.9% |
| Profitability | ||
| Gross margin | 23.9% (better) | 17.8% |
| Operating margin | −1.6% | 6.1% (better) |
| Net margin | −3.1% | 0.06% (better) |
| FCF margin | 5.9% (better) | 5.3% |
| Return on equity | −4.1% | 0.12% (better) |
| Return on invested capital | −1.2% | 6.8% (better) |
| Financial health | ||
| Debt / equity | 0.61 | 0.52 (better) |
| Net debt / EBITDA | – | 1.64 |
| Interest coverage | – | 2.3× |
| Current ratio | 1.45 | 3.29 (better) |
| Altman Z-score | 2.24 (better) | 1.99 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 0.58% | 1.9% (better) |
| Payout ratio | – | 700% |
| Years of dividend growth | 3 (better) | 0 |
| Dividend growth, 5Y average | 17.6% (better) | −7.8% |
| Buyback yield | 1.1% | – |
| Shareholder yield | 1.7% | 1.9% (better) |
| Ownership | ||
| Held by institutions | 102% | 4.2% |
| Held by insiders | 1.5% | 0.26% |
| Insider net buying, 12 months | −$3.7M | – |
| Short interest, % of float | 2.1% | 0.21% |
Go deeper
- MTX stock overview
- MTX income statement
- MTX valuation and score
- VHI stock overview
- VHI income statement
- VHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.